| FAIFX | FEVAX | FAIFX / FEVAX | |
| Total Expense Ratio | 0.34 | 1.15 | 30% |
| Annual Report Gross Expense Ratio | 0.34 | 1.15 | 30% |
| Fund Existence | 5 years | 24 years | - |
| Gain YTD | 9.766 | 13.740 | 71% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 140B | 1.63B | 8,594% |
| Annual Yield % from dividends | 3.70 | 1.30 | 285% |
| Returns for 1 year | 8.92 | 12.43 | 72% |
| Returns for 3 years | 28.21 | 36.00 | 78% |
| Returns for 5 years | 32.93 | 31.22 | 105% |
| Returns for 10 years | N/A | 33.17 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| THQ | 19.28 | 0.05 | +0.26% |
| abrdn Healthcare Opportunities Fund | |||
| CGIB | 25.37 | N/A | -0.02% |
| Capital Group Intl Bd ETF USD-Hdg | |||
| MBB | 95.36 | -0.06 | -0.06% |
| iShares MBS ETF | |||
| PGHY | 19.93 | -0.02 | -0.10% |
| Invesco Glb ex-US High Yld Corp Bd ETF | |||
| BBC | 39.56 | -0.76 | -1.88% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||